Chapter 081 : Non–Muscle-Invasive Bladder Cancer (Ta, T1, and CIS)

chapter-081-non-muscle-invasive-bladder-cancer-ta-t1-and-cis

Exit

Question 1 of 1

Time Left

430093

120

block

Postoperative intravesical chemotherapy (administered in the recovery room) is appropriate for which of the following patients?

Select the correct answer(s).

(0/0)

430094

120

none

Which of the following agents is contraindicated for postoperative intravesical chemotherapy (administered in the recovery room)?

Select the correct answer(s).

(0/0)

430095

120

none

Potential advantage(s) of tumor markers such as BTA, stat NMP-22, and UroVysion (FISH) when compared with urinary cytology for monitoring patients with bladder cancer are improved:

Select the correct answer(s).

(0/0)

430096

120

none

Progression rates for low-grade Ta tumors:

Select the correct answer(s).

(0/0)

430097

120

none

General anesthesia is most important when resecting a bladder tumor in which setting?

Select the correct answer(s).

(0/0)

430098

120

none

A healthy 55-year-old man undergoes resection of a 2-cm bladder tumor in a posterior wall bladder diverticulum. Pathology demonstrates a pT1G3 bladder tumor with associated areas of carcinoma in situ (CIS). Muscularis mucosa is involved, but there is no definite muscularis propria in the specimen. Optimal management includes:

Select the correct answer(s).

(0/0)

430099

120

none

The most important principle to follow when resecting tumor near or overlying a ureteral orifice is:

Select the correct answer(s).

(0/0)

430100

120

none

A restaging transurethral resection of bladder tumor (TURBT) with possible postoperative intravesical chemotherapy (administered in the recovery room) is indicated in which of the following situations?

Select the correct answer(s).

(0/0)

430101

120

none

The optimal laser for fulguration of bladder tumors is:

Select the correct answer(s).

(0/0)

430102

120

none

Intravesical mitomycin C chemotherapy for high-risk superficial bladder cancer:

Select the correct answer(s).

(0/0)

430103

120

none

Contraindications to intravesical BCG therapy include all of the following EXCEPT:

Select the correct answer(s).

(0/0)

430104

120

none

The combination of reduced-dose BCG and interferon-α for intravesical therapy is:

Select the correct answer(s).

(0/0)

430105

120

none

Common side effects of thiotepa include:

Select the correct answer(s).

(0/0)

430106

120

none

Long-term (15 years) outcome after intravesical BCG therapy for patients with high-risk non–muscle-invasive bladder cancer include which of the following?

Chapter 081 : Non–Muscle-Invasive Bladder Cancer (Ta, T1, and CIS)

Question 1 of 1

Time Left

Postoperative intravesical chemotherapy (administered in the recovery room) is appropriate for which of the following patients?

Select the correct answer(s).

(0/0)

Which of the following agents is contraindicated for postoperative intravesical chemotherapy (administered in the recovery room)?

Select the correct answer(s).

(0/0)

Potential advantage(s) of tumor markers such as BTA, stat NMP-22, and UroVysion (FISH) when compared with urinary cytology for monitoring patients with bladder cancer are improved:

Select the correct answer(s).

(0/0)

Progression rates for low-grade Ta tumors:

Select the correct answer(s).

(0/0)

General anesthesia is most important when resecting a bladder tumor in which setting?

Select the correct answer(s).

(0/0)

Select the correct answer(s).

(0/0)

The most important principle to follow when resecting tumor near or overlying a ureteral orifice is:

Select the correct answer(s).

(0/0)

A restaging transurethral resection of bladder tumor (TURBT) with possible postoperative intravesical chemotherapy (administered in the recovery room) is indicated in which of the following situations?

Select the correct answer(s).

(0/0)

The optimal laser for fulguration of bladder tumors is:

Select the correct answer(s).

(0/0)

Intravesical mitomycin C chemotherapy for high-risk superficial bladder cancer:

Select the correct answer(s).

(0/0)

Contraindications to intravesical BCG therapy include all of the following EXCEPT:

Select the correct answer(s).

(0/0)

The combination of reduced-dose BCG and interferon-α for intravesical therapy is:

Select the correct answer(s).

(0/0)

Common side effects of thiotepa include:

Select the correct answer(s).

(0/0)

Long-term (15 years) outcome after intravesical BCG therapy for patients with high-risk non–muscle-invasive bladder cancer include which of the following?

Select the correct answer(s).

(0/0)

Understaging for patients with pT1G3 bladder cancer is approximately:

Select the correct answer(s).

(0/0)

Results

Correct

0

Incorrect

0

Skipped

0

Overall Percentage

0%

Rate Quiz